[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

Celcuity Inc (CELC) - Product Pipeline Analysis, 2020 Update

January 2021 | 31 pages | ID: CCCA13737BBDEN
GlobalData

US$ 750.00

E-mail Delivery (PDF)

Download PDF Leaflet

Wire Transfer
Checkout Later
Need Help? Ask a Question
Summary

Celcuity Inc (Celcuity) is a cellular analysis company that develops companion diagnostic tests to identify new patient populations for targeted therapies. The company’s CELx signaling function diagnostic platform utilizes a patient’s living tumor cells to identify the specific abnormal cellular activity. It also develops CELx multi-pathway (MP) signaling function test for breast cancer which measures HER1, HER2, HER3, and c-Met signaling activity in a patient’s live tumor cells. The company partners with pharmaceutical companies to evaluate the efficacy of targeted therapies in patients diagnosed with cancer. Celcuity is headquartered in Minneapolis, Minnesota, the US

This report is a source for data, analysis, and actionable intelligence on the company’s portfolio of pipeline products. The report provides key information about the company, its major products and brands.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.

Scope:
  • The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments
  • The report analyzes all pipeline products in development for the company Celcuity Inc
  • The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)
  • The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date
  • The report provides detailed description of products in development, technical specification and functions
  • The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design , trial status and phase, estimated start and end date.
Reasons to Buy:
  • Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape
  • Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio
  • To formulate effective Research & Development strategies
  • Develop market-entry and market expansion strategies
  • Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return
  • Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Develop competition strategies by identifying the status and likely launch of the competitors’ pipeline products through review of the clinical trials, stage and of development, etc
  • Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio
Note: Some sections may be missing if data is unavailable for the company
Table of Contents
List of Tables
List of Figures
Celcuity Inc Company Overview
Celcuity Inc Company Snapshot
Celcuity Inc Pipeline Products and Ongoing Clinical Trials Overview
Celcuity Inc – Pipeline Analysis Overview
Celcuity Inc - Key Facts
Celcuity Inc - Major Products and Services
Celcuity Inc Pipeline Products by Development Stage
Celcuity Inc Pipeline Products Overview
CELsignia Test - Bladder Cancer
CELsignia Test - Bladder Cancer Product Overview
CELsignia Test - Breast Cancer
CELsignia Test - Breast Cancer Product Overview
CELsignia Test - Colon Cancer
CELsignia Test - Colon Cancer Product Overview
CELsignia Test - Kidney Cancer
CELsignia Test - Kidney Cancer Product Overview
CELsignia Test - Lung Cancer
CELsignia Test - Lung Cancer Product Overview
CELsignia Test - Ovarian Cancer
CELsignia Test - Ovarian Cancer Product Overview
CELx HSF Test
CELx HSF Test Product Overview
CELx Test - Hematological Cancer
CELx Test - Hematological Cancer Product Overview
Celcuity Inc - Key Competitors
Celcuity Inc - Key Employees
Celcuity Inc - Locations And Subsidiaries
Head Office
Recent Developments
Celcuity Inc, Recent Developments
Dec 11, 2019: Celcuity presents results at the 2019 San Antonio Breast Cancer Symposium evaluating a sub-group of PIK3CA WT breast cancer patients who have hyperactive signaling tumors responsive to PI3K inhibitors
Dec 05, 2019: Celcuity announces appointment of Richard Buller to Board of Directors
Nov 07, 2019: Celcuity reports third quarter 2019 financial results
Sep 09, 2019: Celcuity announces appointment of Eric Lindquist as chief business officer
Aug 08, 2019: Celcuity reports second quarter 2019 financial results
May 20, 2019: Celcuity names Leo Furcht to Board of Directors
May 07, 2019: Celcuity reports first quarter 2019 financial results
Appendix
Methodology
About GlobalData
Contact Us
Disclaimer

LIST OF TABLES

Celcuity Inc Pipeline Products and Ongoing Clinical Trials Overview
Celcuity Inc Pipeline Products by Equipment Type
Celcuity Inc Pipeline Products by Indication
Celcuity Inc, Key Facts
Celcuity Inc, Major Products and Services
Celcuity Inc Number of Pipeline Products by Development Stage
Celcuity Inc Pipeline Products Summary by Development Stage
CELsignia Test - Bladder Cancer - Product Status
CELsignia Test - Bladder Cancer - Product Description
CELsignia Test - Breast Cancer - Product Status
CELsignia Test - Breast Cancer - Product Description
CELsignia Test - Colon Cancer - Product Status
CELsignia Test - Colon Cancer - Product Description
CELsignia Test - Kidney Cancer - Product Status
CELsignia Test - Kidney Cancer - Product Description
CELsignia Test - Lung Cancer - Product Status
CELsignia Test - Lung Cancer - Product Description
CELsignia Test - Ovarian Cancer - Product Status
CELsignia Test - Ovarian Cancer - Product Description
CELx HSF Test - Product Status
CELx HSF Test - Product Description
CELx Test - Hematological Cancer - Product Status
CELx Test - Hematological Cancer - Product Description
Celcuity Inc, Key Employees
Glossary

LIST OF FIGURES

Celcuity Inc Pipeline Products by Equipment Type
Celcuity Inc Pipeline Products by Development Stage

COMPANIES MENTIONED

Quest Diagnostics Inc
Psychemedics Corp
Genomind Inc
Cancer Genetics Inc
Assurex Health Inc


More Publications